Study of TANGO2-related conditions and tissue samples
Part of Genetic & congenital clinical trials.
This study follows people with a TANGO2 gene change and collects medical information and samples over time. It aims to better describe the condition and build a biorepository (a secure collection of samples) to support future research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed TANGO2 gene change known to cause disease
- Your diagnosis is considered TANGO2-related
- You can participate in a natural history (follow-up over time) study
- You are willing to provide and allow storage of study samples
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how GATA2 gene changes affect your blood cells over time. It is for people of any age who have a GATA2 mutation they were born with, and it does not test a new drug—just collects information and samples during regular checkups.
This study tracks the health of people with a confirmed ACTA2 gene change over time to better understand the disease. It may help researchers learn how to improve care for this condition.
This study aims to learn more about health problems caused by changes in the TNPO2 gene. It is a natural history study that will collect information to help understand and care for people with these rare genetic conditions.
This research study analyzes lung cancer tissue samples to understand a protein called TROP2 and how it might help guide treatment decisions. You may qualify if you have non-squamous lung cancer and haven't received prior systemic chemotherapy or immunotherapy for advanced disease.
This natural history study looks at how GATA2 deficiency (a genetic condition) affects health over time. It may help doctors better understand complications and plan future care, and it includes genetic testing and stored samples.
This study sets up a database and collection of “biosamples” (like blood or other body samples) from people with tuberous sclerosis complex (TSC) or sporadic lymphangioleiomyomatosis (LAM). The goal is to better understand how these conditions change over time and support future research.
Hear when a new TANGO2-related Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.